SOM Biotech has been granted SME status as micro-sized enterprise in research and development by the European Medicine Agency (EMA). The main incentives include: fee reductions in regulatory procedures and scientific advice, administrative assistance, and more economical access to various services provided by EMA.
SOM Biotech will attend BioBusiness 2012 that will take place from 31 January to 2 February 2012 in London. BioBusiness is the leading high-level BioPharma strategy and bio-partnering conference.
SOM Biotech will present the company to private investors during the Biotech Showcase™ and J.P. Morgan Healthcare Conference that will take place from 9th to 12th January 2012 in San Francisco, CA.
SOM presents in the 5th Barcelona Healthcare Investment Forum 2011. The forum has become a meeting point between biotech start-up companies, medical devices and healthcare services and investors.
SOM presents in the 4th ESADE BAN Investment Forum 2011 in Valencia (Spain). The Investment Forum is designed as a meeting point for those seeking investment opportunities and entrepreneurs with innovative projects looking to finance their business ventures during the initial stages.